Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone

References

• RoodmanGDMechanisms of bone metastasisN Engl J Med2004350161655166415084698
   PubMed Web of Science ®Google Scholar
• ClarkPETortiFMProstate cancer and bone metastases: medical treatmentClin Orthop2003415S148S157
   Google Scholar
• MundyGRMetastasis to bone: causes, consequences and therapeutic opportunitiesNat Rev Cancer20022858459312154351
   PubMed Web of Science ®Google Scholar
• GuiseTAMundyGRCancer and boneEndocr Rev199819118549494779
   PubMed Web of Science ®Google Scholar
• ChenYCSosnoskiDMMastroAMBreast cancer metastasis to the bone: mechanisms of bone lossBreast Cancer Res201012621521176175
   PubMed Web of Science ®Google Scholar
• BubendorfLSchopferAWagnerUMetastatic patterns of prostate cancer: an autopsy study of 1,589 patientsHum Pathol200031557858310836297
   PubMed Web of Science ®Google Scholar
• PsailaBLydenDThe metastatic niche: adapting the foreign soilNat Rev Cancer20099428529319308068
   PubMed Web of Science ®Google Scholar
• DomchekSMYoungerJFinkelsteinDMSeidenMVPredictors of skeletal complications in patients with metastatic breast carcinomaCancer200089236336810918167
   PubMed Web of Science ®Google Scholar
• ChaudhariKRKumarAKhandelwalVKBone metastasis targeting: a novel approach to reach bone using zoledronate anchored PLGA nanoparticle as carrier system loaded with docetaxelJ Control Release2012158347047822146683
   PubMed Web of Science ®Google Scholar
• JamalSALjunggrenOStehman-BreenCEffects of denosumab on fracture and bone mineral density by level of kidney functionJ Bone Miner Res20112681829183521491487
   PubMed Web of Science ®Google Scholar
• XueBWangYTangXHBiodegradable self-assembled MPEG-PCL nanoparticles for hydrophobic oridonin delivery in vitroJ Biomed Nanotechnol201281808922515096
   PubMedGoogle Scholar
• GongCDengSWuQImproving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric nanoparticlesBiomaterials20133441413143223164423
   PubMed Web of Science ®Google Scholar
• DuanXMWangPMenKTreating colon cancer with a suicide gene delivered by self-assembled cationic MPEG–PCL nanoparticlesNanoscale2012472400240722388488
   PubMedGoogle Scholar
• ShiSZhuXGuoQSelf-assembled mPEG-PCL-g-PEI nanoparticles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitroInt J Nanomedicine201271749175922619525
   PubMed Web of Science ®Google Scholar
• WangHMLiuJTaoSTetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery systemInt J Nanomedicine20151015671568526388691
   PubMedGoogle Scholar
• ChengTLMurphyCMRavarianRBisphosphonate-adsorbed ceramic nanoparticles increase bone formation in an injectable carrier for bone tissue engineeringJ Tissue Eng20156204173141560944826668709
   PubMedGoogle Scholar
• MillerSPanHWangDBowmanBKopeckováPKopecekJFeasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E1 to promote bone formation in aged, estrogen-deficient ratsPharm Res200825122889289518758923
   PubMedGoogle Scholar
• lmazrooaSAWooSBisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a reviewJ Am Dent Assoc2009140786487519571050
   PubMedGoogle Scholar
• OuyangLHuangWHeGGuoLBone targeting prodrugs based on peptide dendrimers, synthesis and hydroxyapatite binding in vitroLett Org Chem200964272277
   Google Scholar
• OgawaKIshizakiATakaiKDevelopment of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriersPLoS One2013812e8433524391942
   PubMedGoogle Scholar
• WangDMillerSCShlyakhtenkoLSOsteotropic peptide that differentiates functional domains of the skeletonBioconjug Chem20071851375137817705416
   PubMed Web of Science ®Google Scholar
• WangDMillerSCSimaMSynthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systemsBioconjug Chem200314585385913129387
   PubMedGoogle Scholar
• HolohanCVan SchaeybroeckSLongleyDBJohnstonPGCancer drug resistance: an evolving pradigmNat Rev Cancer2013131071472624060863
   PubMed Web of Science ®Google Scholar
• GuptaSCPatchvaSKohWAggarwalBBDiscovery of curcumin, a component of golden spice, and its miraculous biological activitiesClin Exp Pharmacol Physiol201239328329922118895
   PubMed Web of Science ®Google Scholar
• LinSSLaiKCHsuSCCurcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF)Cancer Lett2009285212713319477063
   PubMed Web of Science ®Google Scholar
• AnuchapreedaSThanarattanakornPSittipreechacharnSTimaSChanaratPLimtrakulPInhibitory effect of curcumin on MDR1 gene expression in patient leukemic cellsArch Pharm Res2006291086687317121181
   PubMedGoogle Scholar
• KunnumakkaraABAnandPAggarwalBBCurcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteinsCancer Lett2008269219922518479807
   PubMed Web of Science ®Google Scholar
• RohanizadehRDengYVerronETherapeutic actions of curcumin in bone disordersBonekey Rep2016579326962450
   PubMedGoogle Scholar
• SuwannateepNBanlunaraWWanichwecharungruangSPChiablaemKLirdprapamongkolKSvastiJMucoadhesive curcumin nanospheres: biological activity, adhesion to stomach mucosa and release of curcumin into the circulationJ Control Release2011151217618221241751
   PubMed Web of Science ®Google Scholar
• RejinoldNSSreerekhaPRChennazhiKPNairSVJayakumarRBiocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug deliveryInt J Biol Macromol201149216117221536066
   PubMed Web of Science ®Google Scholar
• YallapuMMJaggiMChauhanSCBeta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cellsColloid Surf B Biointerfaces201079111312520456930
   PubMed Web of Science ®Google Scholar
• RejinoldNSMuthunarayananMDivyaraniVVCurcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug deliveryJ Colloid Interface Sci20113601395121549390
   PubMedGoogle Scholar
• StandardASTMStandard practice for assessment of hemolytic properties of materialsTech Rep2008F75608
   Google Scholar
• DanafarHSharafiAManjiliHKSulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cellsPharma Dev Technol201625110
   Google Scholar
• FuYFuTWangHAspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluationActa Biomater201410114583459625050775
   PubMed Web of Science ®Google Scholar
• StuartAJSmithDAUse of the fluorochromes xylenol orange, calcein green, and tetracycline to document bone deposition and remodeling in healing fractures in chickensAvian Dis19923624474491627115
   PubMedGoogle Scholar
• KasugaiSFujisawaRWakiYSelective drug delivery system to bone: small peptide (Asp)6 conjugationJ Bone Miner Res200015593694310804024
   PubMed Web of Science ®Google Scholar
• GouMLMenKShiHSCurcumin-loaded biodegradable polymeric nanoparticles for colon cancer therapy in vitro and in vivoNanoscale20123415581567
   Google Scholar
• LiXChenTXuLPreparation of curcumin nanoparticles and the in vitro and in vivo evaluation for cancer therapyJ Biomed Nanotechnol20141081458146825016646
   PubMedGoogle Scholar
• OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
   PubMed Web of Science ®Google Scholar
• WisseEBraetFLuoDStructure and function of sinusoidal lining cells in the liverToxicol Pathol19962411001118839287
   PubMed Web of Science ®Google Scholar
• FuYCFuTFWangHJAspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluationActa Biomater201410114583459625050775
   PubMed Web of Science ®Google Scholar
• ChenLQFangLLingJDingCZKangBHuangCZNanotoxicity of silver nanoparticles to red blood cells: size dependent adsorption, uptake, and hemolytic activityChem Res Toxicol201528350150925602487
   PubMed Web of Science ®Google Scholar
• WeiXGongCGouMBiodegradable poly (epsilon-caprolactone)-poly (ethylene glycol) copolymers as drug delivery systemInt J Pharm2009381111819664700
   PubMedGoogle Scholar
• ShiSShiKTanLThe use of cationic MPEG-PCL-g-PEI nanoparticles for co-delivery of Msurvivin T34A gene and doxorubicinBiomaterials201435154536454724582554
   PubMed Web of Science ®Google Scholar
• HouJFanDZhaoLDegradability, cytocompatibility, and osteogenesis of porous scaffolds of nanobredigite and PCL-PEG-PCL compositeInt J Nanomedicine2016113545355527555774
   PubMed Web of Science ®Google Scholar
• GouMWeiXMenKPCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent deliveryCurr Drug Targets20111281131115021443476
   PubMed Web of Science ®Google Scholar
• KinderMChislockEMBussardKMMetastatic breast cancer induces an osteoblast inflammatory responseExp Cell Res2008314117318317976581
   PubMed Web of Science ®Google Scholar
• YamaguchiMMooreTWSunASnyderJPShojiMNovel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibitionIntegr Biol (Camb)20124890591322751853
   PubMedGoogle Scholar
• ShuklaPMathurKumarANanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasisJ Biomed Nanotechnol201410113381339126000396
   PubMedGoogle Scholar
• ChangRSunLWebsterTJShort communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblastsInt J Nanomedicine20149146146524453488
   PubMedGoogle Scholar